Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies (Cohort B)
The purpose of this phase II trial (Cohort B) is to evaluate the safety and efficacy of high dose Vitamin C in patients with metastatic solid tumors, including pancreatic cancer, with extended RAS (e.g. KRAS or NRAS) or BRAF mutation and who have received prior systemic treatment.
Study ID: 1610017688
Trial Phase: Phase II
Trial Sponsor: Weill Medical College of Cornell University
Therapies Used in This Trial: Ascorbic Acid